Global Occlusion Devices Market Size, Share, Opportunities And Trends By Type (Occlusion Removal Devices, Embolization Devices, Tubal Occlusion Devices), By Application (Cardiology, Gynaecology, Neurology, Urology, Others), By End Users (Hospitals, Ambulatory SurgIcal Centers) And By Geography - Forecasts From 2019 To 2024

  • Published : Mar 2020
  • Report Code : KSI061611891
  • Pages : 114

The global occlusion devices market is expected to reach $XX billion by 2023 from $XX billion in 2017 growing at a CAGR of XX%. Occlusion refers to the blockage or closure in the blood vessel or any other organ of the body. Occlusion devices are used to remove such blockages to retain blood flow in the vessel or the organising minimally invasive surgeries. The devices are used to cure to cure cardiovascular defects, gynaecological defects, neurological defects etc. The market is expected to show a robust growth during the given forecast period. The growth in the market may be attributed to the rising patient population base owing to the increase in the prevalence of cardiovascular, neurological and other disorders needing occlusion removal. Rising adoption of the minimally invasive surgeries across the globe coupled with the favourable reimbursement policies will also boost the market for the occlusion devices through to2023. However, stringent regulatory requirements for the market approval of such devices along with the lack of trained and skilled professionals might restrain the growth of the market the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global occlusion devices market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global occlusion devices market.

Major industry players profiled as part of the report are Terumo Europe NV, Abbott and Medtronic among others.

Segmentation

By Type

Occlusion Removal Devices

Embolization Devices

Tubal Occlusion Devices


By Application

Cardiology

Gynaecology

Neurology

Urology

Others


By End Users

Hospitals

Ambulatory SurgIcal Centers


By Geography

North America

United States

Canada

Others


South America

Brazil

Argentina

Others


Europe

United Kingdom

Germany

France

Others


Middle East and Africa

Saudi Arabia

UAE

Israel

Others


Asia Pacific

China

India

Australia

South Korea

Others

 

Key questions answered by the report

What will be the global occlusion devices market size from 2018 to 2023?

How are the major drivers and restraints affecting the global occlusion devices market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth


1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings of the Study
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. Global Occlusion Devices Market Forecast by Type  
5.1. Occlusion Removal Devices
5.2. Embolization Devices
5.3. Tubal Occlusion Devices
6. Global Occlusion Devices Market Forecast by Application
6.1. Cardiology
6.2. Gynaecology
6.3. Neurology
6.4. Urology
6.5. Others
7. Global Occlusion Devices Market Forecast by End Users
7.1. Hospitals
7.2. Ambulatory Surgical Centers
8. Global Occlusion Devices Market Forecast by Geography 
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil 
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.4.4. Others
8.5. Asia Pacific 
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others 
9. Competitive intelligence
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. Company Profiles
10.1. Abbott
10.1.1. Overview 
10.1.2. Financials
10.1.3. Product and Services 
10.1.4. Recent Developments
10.2. Penumbra, Inc.
10.2.1. Overview 
10.2.2. Financials
10.2.3. Product and Services 
10.2.4. Recent Developments
10.3. Medtronic
10.3.1. Overview 
10.3.2. Financials
10.3.3. Product and Services 
10.3.4. Recent Developments
10.4. AtriCure, Inc.
10.4.1. Overview 
10.4.2. Financials
10.4.3. Product and Services 
10.4.4. Recent Developments
10.5. Terumo Europe NV
10.5.1. Overview 
10.5.2. Financials
10.5.3. Product and Services 
10.5.4. Recent Developments
10.6. Neuravi
10.6.1. Overview 
10.6.2. Financials
10.6.3. Product and Services 
10.6.4. Recent Developments
10.7. Prytime Medical Devices, Inc
10.7.1. Overview 
10.7.2. Financials
10.7.3. Product and Services 
10.7.4. Recent Developments
10.8. Acrostak Int.
10.8.1. Overview 
10.8.2. Financials
10.8.3. Product and Services 
10.8.4. Recent Developments
10.9. ArtVentive Medical Group, Inc.
10.9.1. Overview 
10.9.2. Financials
10.9.3. Product and Services 
10.9.4. Recent Developments
10.10. EndoShape, Inc.
10.10.1. Overview 
10.10.2. Financials
10.10.3. Product and Services 
10.10.4. Recent Developments

Abbott

Penumbra, Inc.

Medtronic

AtriCure, Inc.

Terumo Europe NV

Neuravi

Prytime Medical Devices, Inc

Acrostak Int.

ArtVentive Medical Group, Inc.

EndoShape, Inc.